Dexamethasone, Carmustine, Etoposide, Cytarabine, and Melphalan (Dexa-BEAM) Followed by High-Dose Chemotherapy and Stem Cell Rescue - A Highly Effective Regimen for Patients with Refractory or Relapsed Indolent Lymphoma-Reference-Cited by-同舟云学术

Dexamethasone, Carmustine, Etoposide, Cytarabine, and Melphalan (Dexa-BEAM) Followed by High-Dose Chemotherapy and Stem Cell Rescue - A Highly Effective Regimen for Patients with Refractory or Relapsed Indolent Lymphoma

Published:2000-01 Issue:1-2 Volume:37 Page:115-123
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Josting A.,Reiser M.,Wickramanayake P. Dias,Rueffer U.,Draube A.,Söhngen D.,Tesch H.,Wolf J.,Diehl V.,Engert A.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428190009057634

Reference35 articles.

1. Treatment of Non-Hodgkin's Lymphoma

2. The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas

3. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with 131I-anti-CD20 antibody and stem cell rescue;Annals of Hematology;2011-03-01

2. Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease;British Journal of Haematology;2007-03

3. Effect of dexamethasone on voltage-gated K + channels in Jurkat T-lymphocytes;Pfl�gers Archiv European Journal of Physiology;2003-11-01

4. Current treatment of follicular non-Hodgkin's lymphoma;European Journal of Cancer;2002-06

5. Induction of Apoptosis by Cladribine (2-CdA), Gemcitabine and Other Chemotherapeutic Drugs on CD34 + /CD38 + and CD34 + /CD38 - Hematopoietic Progenitor Cells: Selective Effects of Doxorubicin and 2-CdA with Protection of Immature Cells;Leukemia & Lymphoma;2002-01